FGF21 can negatively regulate TGF-β-p53-Smad2/3-mediated epithelial-to-mesenchymal transition by activating AKT for reducing diabetes-induced renal fibrosis (Lin et al., 2020). The gene discussed is FGF21; the disease is diabetes mellitus.